SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 93.60 R     -9.76 (-9.44%) Volume: 1.38m 4:00 PM EST 28-Feb-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities107/03/2018
4/A[Amend] Statement of changes in beneficial ownership of securities107/03/2018
8-KCurrent report pursuant to Section 13 or 15(d)906/27/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
4Statement of changes in beneficial ownership of securities106/21/2018
8-KCurrent report pursuant to Section 13 or 15(d)406/19/2018
4Statement of changes in beneficial ownership of securities106/04/2018
DEFA14AAdditional proxy soliciting materials - definitive1106/04/2018
CT ORDERConfidential treatment order105/22/2018
8-KCurrent report pursuant to Section 13 or 15(d)30605/22/2018
456789101112131415161718